All articles tagged with #variant nb181
A new COVID-19 variant, NB.1.8.1, nicknamed 'razor blade throat' due to severe sore throat symptoms, has been detected in several U.S. states. It appears more transmissible but does not currently cause more severe illness. Experts recommend vaccination, good hygiene, and preventive measures to reduce spread.
The Covid variant NB.1.8.1, originating from Omicron, has rapidly spread globally, particularly in Asia, the US, and Australia, with increased transmissibility but no evidence of increased severity. It is monitored by WHO, and current vaccines remain effective against severe illness.
Public health experts are monitoring the new COVID-19 variant NB.1.8.1, which has mutations that may increase its transmissibility and could lead to a summer surge in cases in the U.S. Although it doesn't cause more severe illness, lower vaccination rates and waning immunity could contribute to rising cases, especially among older adults. Vaccination and antiviral treatments remain effective tools for protection.
A new COVID-19 variant, NB.1.8.1, has emerged with similar symptoms to other variants but may be more transmissible due to mutations. It is currently rare in the US, and there is no evidence of increased severity. Vaccines are expected to remain effective against severe illness, especially for high-risk groups. Most people can recover at home, but severe symptoms require medical attention.
The WHO has issued a warning about rising COVID-19 activity in the Western Pacific, Southeast Asia, and Eastern Mediterranean regions, driven by the new variant NB.1.8.1, with global test positivity reaching 11%, the highest since July 2024, though hospitalizations and deaths remain underreported.
A new COVID-19 variant, NB.1.8.1, a sublineage of Omicron, is spreading globally and may infect cells more efficiently while partially evading immunity. Although it appears more transmissible, there is no evidence yet of increased severity. Public health measures, including vaccination and booster shots, remain crucial as the variant gains prominence in Australia and Asia.